MetaCap

Alpha Tau Medical (DRTS) vs SI-BONE (SIBN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Alpha Tau Medical (DRTS) has outperformed SI-BONE (SIBN) over the past year, gaining 207.7% versus a gain of 21.7%. Over five years, SIBN leads with a +18.5% price change compared with +18.5% for DRTS. Alpha Tau Medical is the larger company by market cap ($1.09 billion vs $1.07 billion), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

DRTS+207.72%SIBN+21.69%
+323%+133%-58%
Nov 21, 20251 yearNov 20, 2026
DRTS+18.62%SIBN+11.72%
+60%-13%-86%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

DRTS versus SIBN key metrics
MetricDRTSSIBN
Share price$11.76$23.73
Market cap$1.09B$1.07B
1-day change+3.93%-0.08%
YTD return+137.47%+20.33%
1-year return+207.72%+21.69%
5-year return+18.50%+18.53%
EPS (TTM)$-1.04$-0.31
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$200.93M
Revenue growth (YoY)—+20.19%
Net income (latest FY)$-42.63M$-18.90M
Gross margin—79.57%
Operating margin—-11.11%
Net margin—-9.41%
52-week high$15.79$25.92
52-week low$3.65$11.48
Distance from 52-week high-25.55%-8.45%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+75.24%+12.85%
Average volume591.88K709.79K
Shares outstanding92.48M45.11M
Employees121376
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • DRTS has outperformed SIBN by 186.0 percentage points over the past year.

About Alpha Tau Medical

DRTS stock →

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors.

Health Care · Medical/Dental Instruments · 121 employees

About SI-BONE

SIBN stock →

SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products.

Health Care · Medical/Dental Instruments · 376 employees

DRTS vs SIBN FAQ

Which is bigger, Alpha Tau Medical or SI-BONE?

Alpha Tau Medical (DRTS) is larger, with a market capitalization of $1.09B compared with $1.07B for SI-BONE (SIBN).

Which stock has performed better over the past year, DRTS or SIBN?

DRTS returned +207.72% over the past 12 months, compared with +21.69% for SIBN (price return, excluding dividends). Past performance does not predict future results.

Are Alpha Tau Medical and SI-BONE in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons